Overview

Nitric Oxide in Myocardial Infarction Size

Status:
Terminated

Trial end date:
2008-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess whether or not inhaled nitric oxide can decrease myocardial infarction (MI) size at 48-72 hours in patients presenting with an ST segment elevation MI (STEMI) who undergo successful percutaneous coronary intervention.

Phase:

Phase 2

Details

Lead Sponsor:

Mallinckrodt

Treatments:

Nitric Oxide